Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Haydock
CUE-101, a Novel HPV16 E7-pHLA-Il-2-Fc Fusion Protein, Enhances Tumor Antigen Specific T Cell Activation for the Treatment of HPV16-Driven Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Human HSP70 and Modified HPV16 E7 Fusion DNA Vaccine Induces Enhanced Specific CD8+ T Cell Responses and Anti-Tumor Effects
Oncology Reports
Medicine
Cancer Research
Oncology
HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis
Cell
Biochemistry
Genetics
Molecular Biology
HPV16 E7 Increases COX‑2 Expression and Promotes the Proliferation of Breast Cancer
Oncology Letters
Cancer Research
Oncology
Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity and Abolish Established TC-1 Graft Tumor
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
A Pilot Study of pNGVL4a-CRT/E7(detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-Hpv16 E7 Oncoprotein Monoclonal Antibodies
Viruses
Virology
Infectious Diseases
Adoptive T-Cell Therapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
International Journal of Hematology
Hematology
Role of IL-2 Secreted by PADRE-specific CD4+ T Cells in Enhancing E7-Specific CD8+ T-Cell Immune Responses
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Chimeric Papillomavirus Virus-Like Particles Elicit Antitumor Immunity Against the E7 Oncoprotein in an HPV16 Tumor Model
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
